UNSPSC 51373463: Guaifenesin/hydrocodone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373463 Guaifenesin/hydrocodone is a Commodity code whose recent procurement activity shows little alignment with the code's nominal scope. The two recent state and local opportunities tagged under this code actually solicit naloxone and safe drug deactivation systems (Seminole County, Florida), and generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). Neither opportunity specifically targets guaifenesin/hydrocodone products. The code appears to have minimal recent state and local procurement activity in its stated pharmaceutical category, and the mismatch between the code label and the actual work being solicited suggests either a cataloging inconsistency or very sparse use of this code for its intended purpose.

The two recent opportunities that do carry this code show geographically dispersed activity across Florida and Minnesota, with the Florida procurement (Seminole County IFB60459723LAS, due July 26, 2023) representing a single-jurisdiction health department purchase, and the Minnesota opportunity (MMCAP S1070000015802, due March 26, 2026) representing a multistate cooperative purchasing vehicle administered by the Minnesota Department of Administration. Because the recent solicitations do not address the code's stated commodity and show no pattern of repeat buyers or concentrated geographic demand for guaifenesin/hydrocodone specifically, this code warrants a skip unless your firm has direct intelligence of unpublished or pipeline demand in this therapeutic category.